AGTC Genomics

01/01/2026

16/12/2025

𝗙𝗿𝗼𝗺 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝘁𝗼 𝗗𝗮𝘁𝗮 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆: 𝗥𝗡𝗔-𝘀𝗲𝗾 𝗦𝗵𝗮𝗿𝗶𝗻𝗴 𝗮𝘁 𝗨𝗧𝗔𝗥💡

We had an insightful sharing session with the students, researchers, and lecturers at UTAR Kampar during our RNA Sequencing Talk. It was a pleasure to co-organised the event and share our expertise on how RNA-seq enables gene expression analysis, biological discovery, and impactful research outcomes.

A heartfelt thank you to our wonderful speakers, Ms.Hiu Ching Toh and Ms. Xin Yi Chew, for delivering clear and comprehensive insights into RNA-seq workflows, data interpretation, and real-world applications.

I would also like to express my deepest appreciation to the event organisers from Faculty of Science, Universiti Tunku Abdul Rahman (UTAR) Kampar campus — Dr. Eddy Cheah and Ms. Luke Choy May, for the warm invitation and seamless support in making this event a success.

Stay tuned and join us in future collaborations as we continue driving genomics education forward and empowering impactful research projects 🧬

16/12/2025

🔬 𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗚𝗲𝗻𝗼𝗺𝗶𝗰𝘀 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗶𝗻 𝗩𝗶𝗲𝘁𝗻𝗮𝗺: 𝗔𝗚𝗧𝗖 𝗚𝗲𝗻𝗼𝗺𝗶𝗰𝘀 𝗦𝘁𝗿𝗲𝗻𝗴𝘁𝗵𝗲𝗻𝘀 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻 𝘄𝗶𝘁𝗵 𝗩𝗶𝗲𝘁𝗻𝗮𝗺 𝗡𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗨𝗻𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝘆 (𝗩𝗡𝗨) 𝗛𝗮𝗻𝗼𝗶

AGTC Genomics is pleased to share the outcomes of our recent business visit to Vietnam National University (VNU) Hanoi, where we held highly productive discussions centred on deepening research collaboration in advanced genomics and precision medicine.

The engagement brought together academic leaders and genomics experts for an in-depth exchange of knowledge, with a strong emphasis on building a long-term research partnership to accelerate Vietnam’s capabilities across key scientific domains.

Our discussions focused on:
🧬 Joint research initiatives in cancer genomics, rare diseases, multi-omics, and population genomics
💊 Pharmacogenomics (PGx) research collaboration to support safer, personalised therapies for the Vietnamese population
🔎 Co-development of genomic databases and analytic pipelines to better understand Vietnam’s genetic landscape
📘 Establishing visiting lectureships, student training programs, and co-supervised research projects
🤝 Exploring opportunities for grant applications, shared infrastructure, and long-term research exchange

This strategic engagement marks an important step toward fostering a robust genomics research ecosystem in Vietnam—bridging academic excellence at VNU with AGTC Genomics’ ISO 15189 and CAP-accredited technology platforms and regional expertise.

We look forward to building a strong and sustainable research partnership with VNU Hanoi, working together to advance genomics-driven discoveries that will benefit science, healthcare, and society across the region.

Bioeconomy Corporation
MRANTI
Kementerian Sains, Teknologi dan Inovasi (MOSTI)Chang Lih Kang
KEMENTERIAN KESIHATAN MALAYSIA
Chang Lih Kang

16/12/2025

🚀 𝗦𝘁𝗿𝗲𝗻𝗴𝘁𝗵𝗲𝗻𝗶𝗻𝗴 𝗥𝗲𝗴𝗶𝗼𝗻𝗮𝗹 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆: 𝗔𝗚𝗧𝗖 𝗚𝗲𝗻𝗼𝗺𝗶𝗰𝘀 𝗘𝗻𝗴𝗮𝗴𝗲𝘀 𝗛𝘂𝗻𝗴 𝗩𝗶𝗲𝘁 𝗖𝗮𝗻𝗰𝗲𝗿 𝗛𝗼𝘀𝗽𝗶𝘁𝗮𝗹, 𝗛𝗮𝗻𝗼𝗶 𝗶𝗻 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗞𝗻𝗼𝘄𝗹𝗲𝗱𝗴𝗲 𝗘𝘅𝗰𝗵𝗮𝗻𝗴𝗲

AGTC Genomics is pleased to share the success of our recent business visit and productive discussions with Hưng Việt Cancer Hospital, Hanoi—one of Vietnam’s leading centres for cancer care.

The session brought together clinicians, scientists, and industry experts for a meaningful exchange of knowledge on advanced cancer genomics, highlighting the growing importance of precision oncology in improving patient outcomes across the region.

Our dialogue focused on:
🔬 Understanding the genomic landscape in Vietnam and local clinical needs
🧬 Exploring state-of-the-art cancer genomics solutions, including multi-cancer early detection, comprehensive gene profiling, and liquid biopsy technologies
🤝 Establishing a strong working relationship to support Vietnam’s precision medicine ecosystem
🌏 Identifying opportunities for clinical adoption, capacity building, and research collaboration

This engagement reflects AGTC Genomics’ commitment to advancing accessible, high-quality genomic solutions across Southeast Asia—supported by our ISO 15189 and CAP-accredited clinical genomics laboratory.

We look forward to strengthening this partnership and contributing to Vietnam’s precision oncology roadmap.

Together, we move closer to delivering personalised, data-driven cancer care for every patient.

Bioeconomy Corporation
MRANTI
Kementerian Sains, Teknologi dan Inovasi (MOSTI)
Chang Lih Kang
KEMENTERIAN KESIHATAN MALAYSIA

16/12/2025

𝗘𝗺𝗽𝗼𝘄𝗲𝗿𝗶𝗻𝗴 𝗙𝗮𝗺𝗶𝗹𝗶𝗲𝘀 𝗧𝗵𝗿𝗼𝘂𝗴𝗵 𝗚𝗲𝗻𝗼𝗺𝗶𝗰𝘀: 𝗦𝘂𝗽𝗲𝗿𝗗𝗡𝗔 & 𝗔𝗚𝗧𝗖 𝗚𝗲𝗻𝗼𝗺𝗶𝗰𝘀 𝗮𝘁 𝗖𝗲𝗿𝗶𝘁𝗮 𝗕𝘂𝗻𝗱𝗮 𝗖𝗼𝗺𝗺𝘂𝗻𝗶𝘁𝘆 𝟭𝘀𝘁 𝗔𝗻𝗻𝗶𝘃𝗲𝗿𝘀𝗮𝗿𝘆, 𝗜𝗻𝗱𝗼𝗻𝗲𝘀𝗶𝗮

𝘗𝘳𝘰𝘵𝘦𝘤𝘵𝘪𝘯𝘨 𝘍𝘢𝘮𝘪𝘭𝘪𝘦𝘴, 𝘍𝘳𝘰𝘮 𝘗𝘭𝘢𝘯𝘯𝘪𝘯𝘨 𝘵𝘰 𝘕𝘦𝘸 𝘓𝘪𝘧𝘦.

We extend our sincere appreciation to the Cerita Bunda Community for the invitation to SuperDNA and AGTC Genomics to participate in the 1st Anniversary of Komunitas Cerita Bunda held in Jakarta, Indonesia.

It was an honour to be part of a landmark celebration that brings together parents, parents-to-be, and families in a supportive ecosystem grounded in shared experiences, education, and care. At this milestone event, SuperDNA and AGTC Genomics were proud to contribute by raising awareness on Carrier Screening and Newborn Screening—essential genomic tools that enable early risk identification, informed family planning, and proactive healthcare decisions from the very beginning of life.

Carrier screening helps prospective parents understand inherited genetic risks before or during pregnancy, while newborn screening supports early detection of treatable genetic conditions, enabling timely intervention and better long-term outcomes. Together, these approaches represent a powerful step forward in preventive, family-centred precision medicine.

We commend the Cerita Bunda Community for its leadership in building an inclusive, compassionate platform that champions maternal, child, and family health. We look forward to continued collaboration to advance genomics education and expand access to responsible genetic screening across Indonesia and the region.

Congratulations to Cerita Bunda on this important milestone—together, we are shaping healthier generations ahead.

13/12/2025

🔥 𝗘𝗻𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗬𝗲𝗮𝗿 𝗼𝗻 𝗮 𝗛𝗶𝗴𝗵 𝗡𝗼𝘁𝗲 — 𝗥𝗲𝗰𝗵𝗮𝗿𝗴𝗲𝗱, 𝗥𝗲𝗰𝗼𝗻𝗻𝗲𝗰𝘁𝗲𝗱, 𝗮𝗻𝗱 𝗥𝗲𝗮𝗱𝘆 𝗳𝗼𝗿 𝟮𝟬𝟮𝟲 🔥

Our AGTC Genomics retreat was the perfect way to end the year on a high note, giving our team the space to recharge, reflect, and celebrate everything we have achieved together in 2025.

This year has been nothing short of remarkable:
✨ Record-high earnings and strongest growth to date
✨ A record number of complex cases solved, bringing clarity and answers to patients across the region
✨ The widespread adoption of precision medicine in public and private hospitals — not only in Malaysia, but throughout the Asia-Pacific
✨ Our expanding role in genome research, strengthening and supporting local R&D communities with high-quality genomic data and accredited workflows

The retreat reminded us why our work matters. Every achievement represents a patient who received the right treatment sooner, a clinician empowered with clearer answers, and a researcher supported with reliable data.

Most importantly, it was a celebration of our people — the dedication, passion, and commitment that fuel AGTC’s purpose of making precision medicine and genome research accessible and affordable for everyone.

With renewed energy and aligned purpose, we step into the new year ready to:
🔹 Deliver even more impactful clinical solutions
🔹 Support more hospitals and clinicians
🔹 Empower more research breakthroughs
🔹 Continue raising the standard for genomics in the region

Here’s to a year of growth, gratitude, and shared success —
and to an exciting 2026 ahead for AGTC Genomics.

13/12/2025

𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗧𝗵𝗿𝗼𝘂𝗴𝗵 𝗚𝗲𝗻𝗼𝗺𝗶𝗰𝘀: 𝗖𝗠𝗘 𝗼𝗻 𝗖𝗮𝗻𝗰𝗲𝗿 & 𝗥𝗮𝗿𝗲 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗡𝗚𝗦 𝗮𝘁 𝗣𝗲𝗻𝗮𝗻𝗴 𝗚𝗲𝗻𝗲𝗿𝗮𝗹 𝗛𝗼𝘀𝗽𝗶𝘁𝗮𝗹

We were honoured to collaborate with Penang General Hospital in delivering a Continuing Medical Education (CME) session focused on Next-Generation Sequencing (NGS) for Cancer and Rare Diseases.

Hospital Pulau Pinang, also known as Penang General Hospital, is one of Malaysia’s oldest and largest public hospitals, serving as a major tertiary referral centre for the northern region of Peninsular Malaysia. Established in 1854, it provides comprehensive clinical services, emergency care, specialist treatment, and plays an important role in clinical training and research.

The session brought together clinicians from multiple disciplines to discuss how clinical-grade genomics is transforming precision oncology and enabling more accurate diagnosis of rare and inherited diseases, especially in complex or unresolved cases. Practical insights were shared on test selection, result interpretation, and integrating NGS into routine clinical workflows to better guide treatment and patient management.

As an ISO 15189–accredited and CAP-certified laboratory, AGTC Genomics is committed to delivering genomic testing that meets the highest international standards for quality, reliability, and clinical confidence. Beyond testing, we remain dedicated to supporting continuous medical education and empowering clinicians with trusted genomic insights.

13/12/2025

🌟 𝗔𝗚𝗧𝗖 𝗚𝗲𝗻𝗼𝗺𝗶𝗰𝘀 & 𝗦𝘂𝗽𝗲𝗿𝗗𝗡𝗔 𝗣𝗮𝗿𝘁𝗻𝗲𝗿 𝘄𝗶𝘁𝗵 𝗔𝗹𝗹𝗶𝗮𝗻𝗰𝗲 𝗕𝗮𝗻𝗸 𝘁𝗼 𝗔𝗱𝘃𝗮𝗻𝗰𝗲 𝗖𝗮𝗻𝗰𝗲𝗿 & 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝗴𝗲𝗻𝗼𝗺𝗶𝗰𝘀 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀

We are delighted to collaborate with SuperDNA, and Alliance Bank Malaysia Berhad Malaysia to bring cancer prevention, early detection, and clinical-grade pharmacogenomics awareness to corporate communities.

As precision medicine becomes increasingly essential in modern healthcare, this initiative empowers employees and families with access to evidence-based genomic insights that can guide smarter, safer, and more proactive health decisions.

🔬 𝗙𝗲𝗮𝘁𝘂𝗿𝗲𝗱 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 𝗶𝗻 𝗧𝗵𝗶𝘀 𝗖𝗼𝗿𝗽𝗼𝗿𝗮𝘁𝗲 𝗣𝗿𝗼𝗴𝗿𝗮𝗺:

🧬 𝗖𝗮𝗻𝗰𝗲𝗿𝗥𝗶𝘀𝗸𝗗𝘅𝗧𝗠

A comprehensive genetic risk assessment covering hereditary cancer syndromes — enabling individuals to understand their lifetime predisposition and take preventive steps early.

🩸 𝗖𝗮𝗻𝗰𝗲𝗿𝗦𝗰𝗿𝗲𝗲𝗻𝗗𝘅𝗧𝗠

Our breakthrough multi-cancer early detection (MCED) blood test capable of identifying cancer signals before symptoms appear, supporting earlier intervention and improved outcomes.

💊 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹-𝗚𝗿𝗮𝗱𝗲 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝗴𝗲𝗻𝗼𝗺𝗶𝗰𝘀 (𝗣𝗚𝘅)

ISO15189 & CAP-accredited genetic profiling that helps individuals know how their body responds to medications — reducing adverse drug reactions and guiding safer prescribing.

🌱 𝗪𝗵𝘆 𝗧𝗵𝗶𝘀 𝗠𝗮𝘁𝘁𝗲𝗿𝘀

Prevention and early detection save lives.

In Malaysia and across the region, many cancers are still diagnosed at late stages, and adverse drug reactions remain a major cause of hospital admissions.

By integrating accessible, science-backed genomic testing into corporate wellness programs, we help organisations:

Promote a healthier workforce

Reduce preventable health risks

Empower employees through personalised health insights

Support long-term well-being and productivity

🤝 𝗔 𝗦𝗵𝗮𝗿𝗲𝗱 𝗩𝗶𝘀𝗶𝗼𝗻 𝗳𝗼𝗿 𝗮 𝗛𝗲𝗮𝗹𝘁𝗵𝗶𝗲𝗿 𝗙𝘂𝘁𝘂𝗿𝗲

We thank Alliance Bank for championing preventive healthcare and supporting initiatives that bring precision medicine to more Malaysians. Together, we aim to reshape the future of workplace wellness through genomics-driven preventive care.

At AGTC Genomics and SuperDNA, our mission remains clear:

Make precision medicine accessible, affordable, and impactful for every individual.

06/12/2025

💜 如果早期癌症筛查能像一次抽血一样简单，会怎样？

对数以百万计的人来说，癌症往往是在出现症状后才被发现——
那时往往已经太迟，生活被彻底改变，甚至让人难以承受。

在 AGTC Genomics，我们相信：
不应等到出现症状，人们才开始掌控自己的健康。

这正是我们研发 CancerScreenDx™ 的原因——
一项正在重塑预防医学未来的突破性技术。

🔬 一次检测。超过 110 种癌症。让行动更早一步。

CancerScreenDx™ 不是一项普通的实验室检测。

它是在疾病尚未成为战斗之前，
为生命点亮的最初希望。

只需简单抽取一管血，这项检测即可筛查超过 110 种癌症信号——
其中包括许多目前 没有常规筛查方式 的癌症。

想象一下，它能改变多少人的命运。
想象无数家庭不再陷入不确定的恐惧中。
想象提前知晓所带来的力量。

💡 为什么这很重要？

因为当癌症在早期被发现时：

✨ 治疗效果显著提升
✨ 存活率大幅上升
✨ 医疗成本与并发症减少
✨ 家庭拥有更多时间
✨ 患者重新掌控人生

CancerScreenDx™ 让这一切成为可能——
无需影像检查、无需内窥镜、无需不适。

只需一次简单抽血，
就能换来一份安心。

🛡️ 值得信赖的科学力量

✔ 可筛查 110+ 种癌症类型
✔ 如果检测到癌症信号，可预测最可能的发病组织
✔ 7–14 个工作日 内即可出具结果
✔ 全程由我们通过 ISO 15189 及美国 CAP（病理医师学院）认证 的基因组学实验室完成
✔ 适用于 40 岁以上人群 或任何希望主动进行健康筛查的人

这不只是未来的癌症筛查方式——
而是当下已经实现的突破。

❤️ 您的健康，值得拥有最强的守护

如果您或您关心的人希望积极预防、领先一步、为未来健康投资——
CancerScreenDx™ 将是一个强而有力的起点。

因为早期筛查不仅仅是医学行为，
它关乎情感，
关乎家庭，
关乎希望。

📩 迈出第一步，从今天开始

无论是个人、诊所、医院或健康管理中心——
我们欢迎合作，将早期筛查带给更多社区。

🌐 www.agtcgenomics.com

📞 +6012-520 7981
📧 info@agtcgenomics.com

早筛查，救生命。
CancerScreenDx™ 为此而生。